These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9704123)

  • 1. [Factor VIII antigen and the vascular endothelium in diabetes mellitus].
    Musso R; Cacciola E; Catania NM; Sortino G; Lombardo T; Giustolisi R
    Boll Soc Ital Biol Sper; 1983 Mar; 59(3):283-9. PubMed ID: 9704123
    [No Abstract]   [Full Text] [Related]  

  • 2. Venous occlusion does not release von Willebrand factor, factor VIII or PAI-1 from endothelial cells--the importance of consensus on the use of correction factors for haemoconcentration.
    Wieczorek I; Ludlam CA; MacGregor I
    Thromb Haemost; 1993 Jan; 69(1):91, 93. PubMed ID: 8446947
    [No Abstract]   [Full Text] [Related]  

  • 3. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.
    Chan NN; Fuller JH; Rubens M; Colhoun HM
    Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Aug; 22(8):999-1004. PubMed ID: 16026364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of von Willebrand factor and ristocetin cofactor activity during atrial fibrillation.
    Kalyoncu U; Dizdar O; Erkan Duman A; Karadag O; Tufan A; Yucel O; Tayfur O; Sen D; Ulger Z; Kepez A; Kocabas U; Haznedaroglu I
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):103-8. PubMed ID: 18160605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorheologic and coagulation study in a group of patients with diabetic retinopathy].
    Parenti M; Pasquali R; Sorrenti G; Babini AC; Melchionda N; Palareti G; Poggi M; Tricarico G
    G Clin Med; 1984; 65(9-10):409-18. PubMed ID: 6442246
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators.
    Zareba W; Pancio G; Moss AJ; Kalaria VG; Marder VJ; Weiss HJ; Watelet LF; Sparks CE
    Thromb Haemost; 2001 Sep; 86(3):791-9. PubMed ID: 11583309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
    Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
    Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factor VIII R-Ag and factor VIII Co in diabetes mellitus: correlation between hormonal pattern and type of retinopathy].
    Calle Pascual AL; Bordiu Obanza E; Pérez Villamil B; Martín Alvarez P; Escribá A; Maluenda MP; Espinós D; Marañes JP
    Med Clin (Barc); 1984 Jun; 83(1):4-8. PubMed ID: 6434887
    [No Abstract]   [Full Text] [Related]  

  • 11. Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications.
    De Mattia G; Bravi MC; Laurenti O; Moretti A; Cipriani R; Gatti A; Mandosi E; Morano S
    Diabetes Res Clin Pract; 2008 Feb; 79(2):337-42. PubMed ID: 17949845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired vascular function during short-term poor glycaemic control in Type 1 diabetic patients.
    Sørensen VR; Mathiesen ER; Clausen P; Flyvbjerg A; Feldt-Rasmussen B
    Diabet Med; 2005 Jul; 22(7):871-6. PubMed ID: 15975101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible evidence for an increased factor VIII antigen synthesis in vascular endothelium of diabetic subjects.
    Giustolisi R; Musso R; Russo M; Catania N; Lombardo T; Cacciola E
    Thromb Haemost; 1982 Jun; 47(3):293. PubMed ID: 6810491
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between von Willebrand factor, cholesterol and triglycerides in non-diabetic subjects.
    Lippi G; Salvagno GL; Montagnana M; Guidi GC; Targher G; Franchini M
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):e3-4. PubMed ID: 18042361
    [No Abstract]   [Full Text] [Related]  

  • 15. [High plasma levels of factor VIII and von Willebrand factor in a patient with portal vein thrombosis].
    Günther R; Fölsch UR
    Z Gastroenterol; 2002 Jun; 40(6):409-12. PubMed ID: 12055664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand factor in diabetic angiopathy.
    Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.
    Konduracka E; Galicka-Latala D; Cieslik G; Rostoff P; Fedak D; Sieradzki J; Naskalski J; Piwowarska W
    Diabetes Obes Metab; 2008 Sep; 10(9):719-25. PubMed ID: 17941871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of von Willebrand-factor as a marker of endothelial dysfunction in atherosclerotic patients].
    Horváth B; Hegedüs D; Szapáry L; Márton Z; Alexy T; Koltai K; Gyevnár Z; Juricskay I; Tóth K; Késmárky G
    Orv Hetil; 2003 Dec; 144(50):2471-6. PubMed ID: 15067986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The biochemical markers of endothelium dysfunction in patients with diabetic nephropathy].
    Sibireva OF; Kaliuzhin VV; Urazova OI; Kaliuzhina EV; Milovanova TA
    Klin Lab Diagn; 2012 Aug; (8):8-11. PubMed ID: 23097983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.